Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?

While Ping An Healthcare and Technology Company Limited (HKG:1833) might not be the most widely known stock at the moment, it saw a significant share price rise of over 20% in the past couple of months on the SEHK. With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Ping An Healthcare and Technology’s outlook and value based on the most recent financial data to see if the opportunity still exists.

See our latest analysis for Ping An Healthcare and Technology

Is Ping An Healthcare and Technology Still Cheap?

The stock seems fairly valued at the moment according to my valuation model. It’s trading around 12.47% above my intrinsic value, which means if you buy Ping An Healthcare and Technology today, you’d be paying a relatively reasonable price for it. And if you believe the company’s true value is HK$16.95, there’s only an insignificant downside when the price falls to its real value. What's more, Ping An Healthcare and Technology’s share price may be more stable over time (relative to the market), as indicated by its low beta.

What kind of growth will Ping An Healthcare and Technology generate?

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 82% over the next couple of years, the future seems bright for Ping An Healthcare and Technology. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? 1833’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping an eye on 1833, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

So while earnings quality is important, it's equally important to consider the risks facing Ping An Healthcare and Technology at this point in time. For example, we've found that Ping An Healthcare and Technology has 2 warning signs (1 is potentially serious!) that deserve your attention before going any further with your analysis.

If you are no longer interested in Ping An Healthcare and Technology, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.